Double J Stent Clinical Trial
— IJJOfficial title:
Incidence and Factors Associated With Double-J Urinary Stent Infection (IJJ)
Verified date | February 2019 |
Source | Centre Hospitalier Universitaire de Besancon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of the study was to determine the incidence and factors associated with double-J urinary stent infection.
Status | Not yet recruiting |
Enrollment | 800 |
Est. completion date | December 2021 |
Est. primary completion date | April 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients with a double-J stent placement or change in the hospital Exclusion Criteria: - renal transplants less than one year old |
Country | Name | City | State |
---|---|---|---|
France | CHU de Besançon | Besançon |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Besancon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of patients with urinary tract infection associated with double J stent | Number of patients with urinary tract infection associated with double J stent | 6 months | |
Primary | Number of patients with specific clinical data associated with urinary tract infection associated with double J stent | Clinical data (Age, sex, gender, comorbidities, indication of procedure, duration of double J stent placement) will be compared between patient with urinary tract infection and no urinary tract infection associated with double J stent | 6 months | |
Secondary | Number of patients with relapse and/or recurrence after a first urinary tract infection | Number of patients with relapse and/or recurrence after a first urinary tract infection | 6 months |